News Stories, Recent Stories

Vericel and Broad Institute Expected to Open in Burlington in 2024

Two organizations in the field of medicine and biotech are in the works to open at the same location in Burlington and bring hundreds of jobs with them. 

As reported on BNEWS, The Broad Institute and Vericel are in the process of moving to 25-27 Network Drive to occupy new lab space currently under construction. 

Burlington’s Economic Development Department posted on their website, Bring Me to Burlington, an update on the progress of the project and said both organizations are expected to take up occupancy in town in 2024. 

“Both of these innovative companies had originally made a home in Kendall Square,” the post reads. “As a hub for life sciences, it’s no surprise that they were looking to grow in a different direction, 15 miles northwest to be exact. While Vericel will be leaving its previous location entirely, The Broad Institute will expand and grow right here in Burlington while its main campus will remain in Kendall Square.”

Vericel works in the field of advanced sports medicine. 

“Vericel Corporation is a leader in advanced cell therapies for the sports medicine and severe burn care markets, and a developer of patient-specific expanded cell therapies for use in the treatment of patients with severe diseases and conditions,” a letter to the Planning Department used in the company’s initial application states. 

According to the post on Bring Me to Burlington, “The Broad Institute is also within the life sciences field, but approaching it in an even broader sense. Working with researchers at MIT, Harvard, and Harvard-affiliated hospitals, The Broad Institute aims to accelerate biomedical research and genomic medicine for all. In just a few minutes, they can generate a whole human genome’s worth of genetic data, and read gene expression patterns in tissues and in millions of single cells. Their work will benefit humanity for decades to come.”

The Economic Development Department also said the 25-27 Network Drive location will meet the needs of the two organizations and both will benefit the town’s push to grow its medical and biotech industries. 

“With 270,000 square feet between them, 25-27 Network Drive is the perfect location for both companies to grow,” the post reads. “These two giants prove Burlington will also continue to flourish as a leading spot for the life sciences especially since additional commercial spaces are available on Network Drive and throughout Burlington.”

Currently construction to build the necessary lab space and supporting office space is underway at the site. 

Finally, the relocation of the two organizations will provide new employment opportunities in town. 

“With Vericel and The Broad Institute arriving in Burlington sometime in 2024, we can expect a combined 700 employees at 25-27 Network Drive,” the post states. 

Read the full post here